Scientific Programme
 |
14:30 - 16:00 Poster Session 16 - Diagnosis and staging of urothelial tumours II
| 260: The clinical significance of persistent abnormal urine cytology to predict later transitional cell carcinoma demonstration J.H. Han, Seoul (KR) |
| 261: Urine cytology is of no added value in the primary evaluation of patients with hematuria M.C. Hovius, Naarden (NL) |
| 262: Risk-adapted screening in bladder cancer as a new strategy in bladder cancer is feasible using a computer-based questionnaire, RisikoCheck V4.0, evaluated in an international multicentre trial G. Lüdecke, Giessen (DE) |
| 263: Multiple bio-markers for the prediction of bladder cancer recurrence and mortality S.F. Shariat, Dallas (US) |
| 264: Independent predictors of metachronous bladder transitional cell carcinoma after nephroureterectomy for transitional cell carcinoma of the upper urinary tract G. Novara, Verona (IT) |
| 265: Disease progression in bladder cancer: Have we made headway since 1994? V. Varca, Genoa (IT) |
| 266: Serotonin used as prognostic marker of urological tumours F .St. Krause, Erlangen (DE) |
| 267: Effectivity of optical coherence tomography for the diagnosis of urothelial bladder cancer M. Sachs, Berlin (DE) |
| 268: Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin N.T. Schmeller, Salzburg (AT) |
| 269: Completeness of first resection of bladder tumour depending on seniority of the surgeon M.G. Jesuraj, Middlesbrough (GB) |
| 270: Patient awareness of smoking as a risk factor for bladder cancer A. Mihalakis, Athens (GR) |
| 271: Functional imaging of upper urinary tract neoplasm by diffusion-weighted MRI S. Yoshida, Tokyo (JP) |
| 272: Over expression of stathmin is a poor prognostic factor for upper urinary tract urothelial carcinoma S-D. Chung, Taipei (TW) |
| 273: Contemporary evaluation and treatment of chronic unilateral hematuria and upper tract urothelial tumours CA Andreoni, Sao Paulo SP (BR) |
| 274: The presentation of transitional cell carcinoma of the prostate and use of transrectal ultrasound guided biopsy in it?s detection M.G. Neill, Toronto (CA) |